KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average (2016 - 2025)

Historic Equity Average for Medpace Holdings (MEDP) over the last 10 years, with Q4 2025 value amounting to $376.4 million.

  • Medpace Holdings' Equity Average fell 5590.4% to $376.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $376.4 million, marking a year-over-year decrease of 5590.4%. This contributed to the annual value of $642.3 million for FY2025, which is 721.41% down from last year.
  • Medpace Holdings' Equity Average amounted to $376.4 million in Q4 2025, which was down 5590.4% from $233.0 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Equity Average peaked at $925.5 million during Q4 2021, and registered a low of $233.0 million during Q3 2025.
  • In the last 5 years, Medpace Holdings' Equity Average had a median value of $565.1 million in 2023 and averaged $589.4 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 9437.87% in 2024, then crashed by 7167.29% in 2025.
  • Medpace Holdings' Equity Average (Quarter) stood at $925.5 million in 2021, then crashed by 60.22% to $368.1 million in 2022, then surged by 39.88% to $514.9 million in 2023, then surged by 65.75% to $853.5 million in 2024, then crashed by 55.9% to $376.4 million in 2025.
  • Its Equity Average stands at $376.4 million for Q4 2025, versus $233.0 million for Q3 2025 and $383.0 million for Q2 2025.